INCY Competitors
Incyte Corporation
$121.90
-$0.37(-0.30%)
73
Overall
80
Value
72
Tech
68
Quality
Market Cap
$24.85B
Volume
530.53K
52W Range
$89.25 - $132.60
Target Price
$131.64
INCY competitors: AMGN, LGND, LLY, PFE, GERN. Incyte Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
INCY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $468.10 | $253.21B | $23.52 | 2.12% | 66 |
| LGND Ligand Pharmaceuticals Incorporated | $320.20 | $6.34B | $2.35 | - | 64 |
| LLY Eli Lilly and Company | $1437.29 | $1.35T | $35.35 | 0.47% | 63 |
| PFE Pfizer Inc. | $28.89 | $167.86B | $3.05 | 4.46% | 65 |
| GERN Geron Corporation | $0.96 | $657.12M | $-0.03 | - | 43 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $121.90 | -0.3% | 530.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |